Information for Healthcare Professionals — Antipsychotics FDA ALERT [6/16/2008]: FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for … [Read more...] about Antipsychotics — Increased Risk of Mortality In Elderly Patients Treated for Dementia-related psychosis
Anti-Depressant Use
BIG PHARMA — 2008 1st Quarter Results
Eli Lilly and Merck reported their first-quarter results on April 21st At Eli Lilly, earnings are expected to be up 14% year over year, to 95¢ per share, thanks to the success of Zyprexa, its antipsychotic drug, and Cymbalta, its depression treatment. Analysts are less … [Read more...] about BIG PHARMA — 2008 1st Quarter Results
Coming of Age on Antidepressants
Inconvenient Woman has covered the issue of increased suicide rates for preteens and teenagers in previous Blog entries. FDA Requiring Suicide Studies in Drug Trials "...After decades of inattention to the possible psychiatric side effects of experimental medicines, the Food … [Read more...] about Coming of Age on Antidepressants
FDA Approves Wyeth Antidepressant
Read This FDA Press Release to the Partridge Family Theme Song, "Come on Get Happy" "Trav'lin' along, here's a song that we're singing Come on get happy A whole lotta lovin' is what we'll be bringing We'll make you happy We'll make you happy Come on get happy!" Wyeth … [Read more...] about FDA Approves Wyeth Antidepressant
FDA Requiring Suicide Studies in Drug Trials
After decades of inattention to the possible psychiatric side effects of experimental medicines, the Food and Drug Administration is now requiring drug makers to study closely whether patients become suicidal during clinical trials. The new rules represent one of the most … [Read more...] about FDA Requiring Suicide Studies in Drug Trials